518 related articles for article (PubMed ID: 19532026)
41. Commenting on "Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from ACE 2 study" by Jacob A. Winther and colleagues.
Castello LM; Bellan M
Respir Res; 2018 Mar; 19(1):35. PubMed ID: 29490639
[TBL] [Abstract][Full Text] [Related]
42. Eosinopenia as a marker of mortality and length of stay in patients admitted with exacerbations of chronic obstructive pulmonary disease.
Holland M; Alkhalil M; Chandromouli S; Janjua A; Babores M
Respirology; 2010 Jan; 15(1):165-7. PubMed ID: 19947999
[TBL] [Abstract][Full Text] [Related]
43. The clinical utility of biomarkers in asthma and COPD.
Snell N; Newbold P
Curr Opin Pharmacol; 2008 Jun; 8(3):222-35. PubMed ID: 18468485
[TBL] [Abstract][Full Text] [Related]
44. Circulating visfatin in chronic obstructive pulmonary disease.
Liu X; Ji Y; Chen J; Li S; Luo F
Nutrition; 2009 Apr; 25(4):373-8. PubMed ID: 19056239
[TBL] [Abstract][Full Text] [Related]
45. [The role of expired air moisture condensate in assessment of pulmonary inflammation in patients with chronic obstructive pulmonary disease].
Dotsenko EK; Goncharova VA; Kuzubova NA; Kamenova MIu; Egorova NV
Ter Arkh; 2008; 80(3):10-4. PubMed ID: 18441676
[TBL] [Abstract][Full Text] [Related]
46. Predictors of chronic obstructive pulmonary disease exacerbations.
Ishii T; Kida K
Curr Opin Pulm Med; 2014 Mar; 20(2):138-45. PubMed ID: 24406871
[TBL] [Abstract][Full Text] [Related]
47. Pseudomonas aeruginosa in adults with chronic obstructive pulmonary disease.
Murphy TF
Curr Opin Pulm Med; 2009 Mar; 15(2):138-42. PubMed ID: 19532029
[TBL] [Abstract][Full Text] [Related]
48. Proteomics-based biomarkers in chronic obstructive pulmonary disease.
Chen H; Wang D; Bai C; Wang X
J Proteome Res; 2010 Jun; 9(6):2798-808. PubMed ID: 20387909
[TBL] [Abstract][Full Text] [Related]
49. Steroids in acute exacerbations of chronic obstructive pulmonary disease: are nebulized and systemic forms comparable?
Gunen H; Mirici A; Meral M; Akgün M
Curr Opin Pulm Med; 2009 Mar; 15(2):133-7. PubMed ID: 19532028
[TBL] [Abstract][Full Text] [Related]
50. Comparison of tumor markers and inflammatory biomarkers in chronic obstructive pulmonary disease (COPD) exacerbations.
Barouchos N; Papazafiropoulou A; Iacovidou N; Vrachnis N; Barouchos N; Armeniakou E; Dionyssopoulou V; Mathioudakis AG; Christopoulou E; Koltsida S; Bassiakou E
Scand J Clin Lab Invest; 2015 Apr; 75(2):126-32. PubMed ID: 25598350
[TBL] [Abstract][Full Text] [Related]
51. Comorbidities as an element of multidimensional prognostic assessment of patients with chronic obstructive pulmonary disease.
Grabicki M; Parysek H; Batura-Gabryel H; Brodnicka I
J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():297-301. PubMed ID: 19218653
[TBL] [Abstract][Full Text] [Related]
52. [Prognostic markers of COPD. Role of comorbidity].
Alvarez FV; Romero GP
Arch Bronconeumol; 2009; 45 Suppl 4():2-7. PubMed ID: 20116742
[TBL] [Abstract][Full Text] [Related]
53. The acute effect of cigarette smoking on the high-sensitivity CRP and fibrinogen biomarkers in chronic obstructive pulmonary disease patients.
van Dijk WD; Akkermans R; Heijdra Y; Weel Cv; Schermer TR; Scheepers PT; Lenders JW
Biomark Med; 2013 Apr; 7(2):211-9. PubMed ID: 23547816
[TBL] [Abstract][Full Text] [Related]
54. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
Jahnz-Rózyk K; Targowski T; From S
Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
[TBL] [Abstract][Full Text] [Related]
55. Statistical analysis of chronic obstructive pulmonary disease exacerbations in clinical studies: expectations and limitations.
Gillissen A; Glaab T; Lewis M; Buhl R; Worth H
J Physiol Pharmacol; 2009 Nov; 60 Suppl 5():7-11. PubMed ID: 20134031
[TBL] [Abstract][Full Text] [Related]
56. [Chronic obstructive pulmonary disease and pneumonia].
Huerta A; Domingo R; Soler N
Arch Bronconeumol; 2010; 46 Suppl 3():28-31. PubMed ID: 20620690
[TBL] [Abstract][Full Text] [Related]
57. [The role of respiratory infection in exacerbation of chronic obstructive pulmonary disease].
Dacydchenko SV; Bova AA
Klin Med (Mosk); 2007; 85(5):10-5. PubMed ID: 17665597
[TBL] [Abstract][Full Text] [Related]
58. Surfactant protein D: a lung specific biomarker in COPD?
Sin DD; Pahlavan PS; Man SF
Ther Adv Respir Dis; 2008 Apr; 2(2):65-74. PubMed ID: 19124360
[TBL] [Abstract][Full Text] [Related]
59. Inflammatory response in acute viral exacerbations of COPD.
Rohde G; Borg I; Wiethege A; Kauth M; Jerzinowski S; An Duong Dinh T; Bauer TT; Bufe A; Schultze-Werninghaus G
Infection; 2008 Oct; 36(5):427-33. PubMed ID: 18795228
[TBL] [Abstract][Full Text] [Related]
60. Prognostic assessment in COPD without lung function: the B-AE-D indices.
Boeck L; Soriano JB; Brusse-Keizer M; Blasi F; Kostikas K; Boersma W; Milenkovic B; Louis R; Lacoma A; Djamin R; Aerts J; Torres A; Rohde G; Welte T; Martinez-Camblor P; Rakic J; Scherr A; Koller M; van der Palen J; Marin JM; Alfageme I; Almagro P; Casanova C; Esteban C; Soler-Cataluña JJ; de-Torres JP; Miravitlles M; Celli BR; Tamm M; Stolz D
Eur Respir J; 2016 Jun; 47(6):1635-44. PubMed ID: 27103389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
